疫苗诱导的神经氨酸酶交叉识别性别差异影响小鼠H5N1下呼吸道播散
研究比较C57BL/6小鼠接种β-丙内酯灭活全病毒H1N1或H5N1(LAIV骨架)疫苗后的抗体应答性别差异。雌性对全病毒H1N1和H5N1的IgG滴度更高,主要由抗神经氨酸酶(NA)而非血凝素(HA)抗体介导。H1N1疫苗接种雌鼠在致死剂量H5N1攻击后病毒局限于上呼吸道且肺病毒滴度低于雄鼠,提示疫苗诱导的NA特异性抗体性别差异与H5N1呼吸道播散相关。
要点
- 雌鼠接种H1N1或H5N1疫苗后抗NA的IgG滴度高于雄鼠。
- H1N1疫苗雌鼠在H5N1攻击后病毒局限于上呼吸道且肺滴度更低。
- 所有H5N1疫苗接种鼠不分性别均获保护。
核心结论
- 疫苗诱导的NA特异性抗体应答性别差异与H5N1向小鼠下呼吸道播散差异相关。
研究设计与样本
- C57BL/6小鼠接种β-丙内酯灭活全病毒H1N1或H5N1(LAIV骨架)疫苗,采用系统血清学检测抗体应答,并以致死剂量A/Texas/37/2024 H5N1攻击。
主要发现
- 雌鼠对全病毒H1N1和H5N1的IgG滴度高于雄鼠,主要由抗NA而非抗HA的IgG应答介导。
- H1N1疫苗接种雌鼠的交叉反应性H5N1 IgG滴度更高,主要由N1特异性IgG滴度介导。
- IgG2b和IgG2c是主要抗体亚型,雌鼠IgG2b滴度更高且对禽源和人源NA的FcγRIV结合增强。
- 抗体依赖性补体沉积仅在同源HA应答中雌鼠高于雄鼠。
- H1N1疫苗接种雌鼠在攻击后3天病毒局限于上呼吸道且肺病毒滴度低于雄鼠。
临床怎么用
- 在疫苗诱导的交叉反应性流感免疫研究中应考虑性别因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
H5N1 vaccines have been poorly immunogenic in humans, creating a challenge for vaccine development. Seasonal influenza vaccines offer some cross-protection against H5N1, but there has been no consideration of whether protection differs between the sexes. We investigated sex differences in antibody responses following receipt of either beta-propiolactone inactivated whole virus H1N1 or H5N1 (LAIV backbone) vaccines in C57BL/6 mice. Using systems serology assays, vaccination induced strong homologous and heterologous antibody responses, with females generating greater IgG titers than males against whole virus H1N1 and H5N1, which was primarily mediated by greater IgG responses to neuraminidase (NA) than hemagglutinin (HA) protein. Cross-reactive H5N1 IgG titers were greater among H1N1-vaccinated females, and primarily mediated by greater N1-specific IgG titers. IgG2b and IgG2c were the primary antibody isotypes generated in response to these vaccines, with females having greater IgG2b titers and enhanced binding to FcγRIV for avian and human NA than males following either homologous or heterologous vaccination. Antibody-dependent complement deposition was measured as an FcR-mediated non-neutralizing response against HA and NA and was more robust among H1N1 and H5N1 vaccinated females than their male counterparts in response to homologous HA only. Vaccinated females tended to have greater neutralizing antibody titers than males against the homologous vaccine strain, with limited cross-neutralizing antibodies detected in either sexes. Neuraminidase inhibition titers were greater in vaccinated females than males against the heterologous virus following H1N1 vaccination and against both the vaccine and heterologous viruses following H5N1 vaccination. When H1N1 and H5N1 vaccinated mice were challenged with a lethal dose of A/Texas/37/2024 H5N1, all H5N1 vaccinated mice were protected, regardless of sex. Among H1N1 vaccinated mice, while both sexes were protected against disease, H1N1 vaccinated females restricted virus to the upper respiratory tract and had lower pulmonary virus titers than males at 3 days post challenge. These findings highlight that sex differences in vaccine-induced NA-specific antibody responses are associated with differential respiratory dissemination of H5N1 and that sex should be considered in studies of vaccine-induced cross-reactive influenza immunity.
引用
- Chaulagain S, Werner AP, Parish MA, et al. Sex differences in vaccine-induced neuraminidase cross-recognition impact H5N1 dissemination to the lower respiratory tract in mice. Vaccine. 2026. PMID: 42801862. doi:10.1016/j.vaccine.2026.129189
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。